Thus, through its inhibition of the IL-17-induced production of IL-6, GCP-2 and RANKL, IFN-γ can profoundly limit granulopoiesis, mobilisation of neutrophils, and bone destruction, which are all important in joint inflammation. The gene discussed is IFNG; the disease is inflammation.